Healthcare M&A and Valuation
News and Insights

On December 15, 2025, Cencora, Inc. (NYSE: COR) announced a definitive agreement to acquire  the majority of the outstanding equity interests it does not already own in OneOncology, a physician‑led national oncology platform that empowers independent cancer care practices, from private equity firm TPG and other shareholders. The purchase price was approximately $3.6 billion in cash plus retirement of ~$1.3 billion of existing corporate debt, implying total cash consideration

TPG and AmerisourceBergen announced the acquisition of OneOncology from General Atlantic for $2.1 billion. OneOncology is one of the...